NOVARTIS AG (NVSEF)
Clinical trial NCT07498335 updates: 1. start date: 2026-10-02 → 2026-08-26 2. completion date: 2031-01-31 → 2032-12-13 3. primary completion date: 2030-11-29 → 2031-09-15
Clinical trial NCT07498335 updates: 1. start date: 2026-10-02 → 2026-08-26 2. completion date: 2031-01-31 → 2032-12-13 3. primary completion date: 2030-11-29 → 2031-09-15
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical